Fmr LLC Esperion Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 60,032 shares of ESPR stock, worth $163,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,032

Previous 73,170 17.96%

Holding current value

$163,287

Previous $105,000 44.76%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.73 - $1.41 $9,590 - $18,524	-13,138 Reduced 17.96%	60,032 $58,000
Q1 2025 May 12, 2025	SELL	$1.44 - $2.34 $54,851 - $89,132	-38,091 Reduced 34.24%	73,170 $105,000
Q4 2024 Feb 13, 2025	BUY	$1.61 - $3.83 $64,556 - $153,571	40,097 Added 56.34%	111,261 $244,000
Q3 2024 Nov 13, 2024	SELL	$1.61 - $2.73 $9,526 - $16,153	-5,917 Reduced 7.68%	71,164 $117,000
Q2 2024 Aug 13, 2024	SELL	$1.84 - $3.24 $51,685 - $91,011	-28,090 Reduced 26.71%	77,081 $171,000
Q1 2024 May 13, 2024	SELL	$2.02 - $3.02 $346,783 - $518,458	-171,675 Reduced 62.01%	105,171 $281,000
Q4 2023 Feb 13, 2024	BUY	$0.73 - $3.08 $17,363 - $73,257	23,785 Added 9.4%	276,846 $827,000
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $12,076 - $22,518	12,580 Added 5.23%	253,061 $247,000
Q2 2023 Aug 11, 2023	BUY	$1.2 - $1.76 $178,126 - $261,252	148,439 Added 161.27%	240,481 $334,000
Q1 2023 May 11, 2023	SELL	$1.46 - $7.3 $4,280 - $21,403	-2,932 Reduced 3.09%	92,042 $146,000
Q4 2022 Feb 13, 2023	BUY	$5.09 - $8.5 $441,099 - $736,610	86,660 Added 1042.34%	94,974 $591,000
Q3 2022 Nov 10, 2022	SELL	$5.45 - $8.13 $1,934 - $2,886	-355 Reduced 4.1%	8,314 $55,000
Q2 2022 Aug 12, 2022	BUY	$4.77 - $6.67 $9,554 - $13,360	2,003 Added 30.05%	8,669 $55,000
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $22,264 - $37,062	6,666 New	6,666 $31,000

Others Institutions Holding ESPR

# of Institutions

184

Shares Held

106M

Call Options Held

139K

Put Options Held

604K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $181M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account